148 related articles for article (PubMed ID: 32354918)
1. Peritumoral Clefting and Expression of MMP-2 and MMP-9 in Basal Cell Carcinoma of the Skin.
Manola I; Mataic A; Drvar DL; Pezelj I; Dzombeta TR; Kruslin B
In Vivo; 2020; 34(3):1271-1275. PubMed ID: 32354918
[TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
3. High Grade T1 Papillary Urothelial Bladder Cancer Shows Prominent Peritumoral Retraction Clefting.
Džombeta T; Krušlin B
Pathol Oncol Res; 2018 Jul; 24(3):567-574. PubMed ID: 28752222
[TBL] [Abstract][Full Text] [Related]
4. Expression of metalloproteinases (MMP-2 and MMP-9) in basal-cell carcinoma.
Goździalska A; Wojas-Pelc A; Drąg J; Brzewski P; Jaśkiewicz J; Pastuszczak M
Mol Biol Rep; 2016 Oct; 43(10):1027-33. PubMed ID: 27406386
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of stromal MMP-1, MMP-9 and TIMP-1 in basal cell carcinomas of immunosuppressed patients and controls.
Boyd S; Tolvanen K; Virolainen S; Kuivanen T; Kyllönen L; Saarialho-Kere U
Virchows Arch; 2008 Jan; 452(1):83-90. PubMed ID: 18034264
[TBL] [Abstract][Full Text] [Related]
6. Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin.
Omland SH; Wettergren EE; Mollerup S; Asplund M; Mourier T; Hansen AJ; Gniadecki R
BMC Cancer; 2017 Oct; 17(1):675. PubMed ID: 28987144
[TBL] [Abstract][Full Text] [Related]
7. Local immune response in cutaneous basal cell carcinoma.
Omland SH
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975891
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical study of the specific features of expression of matrix metalloproteinases 1, 9 in the photoaged skin, the foci of actinic keratosis and basal cell carcinoma].
Kuznetsova EV; Snarskaya ES; Zavalishina LE; Tkachenko SB
Arkh Patol; 2016; 78(6):17-22. PubMed ID: 28139598
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
[TBL] [Abstract][Full Text] [Related]
10. Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
de Oliveira Poswar F; de Carvalho Fraga CA; Gomes ES; Farias LC; Souza LW; Santos SH; Gomez RS; de-Paula AM; Guimarães AL
Int J Surg Pathol; 2015 Feb; 23(1):20-5. PubMed ID: 24984957
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
Poswar FO; Fraga CA; Farias LC; Feltenberger JD; Cruz VP; Santos SH; Silveira CM; de Paula AM; Guimarães AL
Pathol Res Pract; 2013 Nov; 209(11):705-9. PubMed ID: 24011615
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
[TBL] [Abstract][Full Text] [Related]
13. Peritumoral clefting in basal cell carcinoma: correlation of in vivo reflectance confocal microscopy and routine histology.
Ulrich M; Roewert-Huber J; González S; Rius-Diaz F; Stockfleth E; Kanitakis J
J Cutan Pathol; 2011 Feb; 38(2):190-5. PubMed ID: 21039746
[TBL] [Abstract][Full Text] [Related]
14. Differential immunohistochemical expression of matrix metalloproteinase-10 (MMP-10) in non-melanoma skin cancers of the head and neck.
Kadeh H; Saravani S; Heydari F; Shahraki S
Pathol Res Pract; 2016 Oct; 212(10):867-871. PubMed ID: 27567711
[TBL] [Abstract][Full Text] [Related]
15. Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma.
Jakubowska K; Pryczynicz A; Januszewska J; Sidorkiewicz I; Kemona A; Niewiński A; Lewczuk Ł; Kędra B; Guzińska-Ustymowicz K
Dis Markers; 2016; 2016():9895721. PubMed ID: 27429508
[TBL] [Abstract][Full Text] [Related]
16. Does the peritumoral stroma of basal cell carcinoma recapitulate the follicular connective tissue sheath?
Sellheyer K; Krahl D
J Cutan Pathol; 2011 Jul; 38(7):551-9. PubMed ID: 21366662
[TBL] [Abstract][Full Text] [Related]
17. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas.
Lebeau A; Nerlich AG; Sauer U; Lichtinghagen R; Löhrs U
Anticancer Res; 1999; 19(5B):4257-64. PubMed ID: 10628384
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and E-cadherin immunoreactivity in different basal cell carcinoma histological types.
Vanjaka-Rogošić L; Puizina-Ivić N; Mirić L; Rogošić V; Kuzmić-Prusac I; Babić MS; Vuković D; Mardešić S
Acta Histochem; 2014 Jun; 116(5):688-93. PubMed ID: 24485332
[TBL] [Abstract][Full Text] [Related]
19. Morphometric characteristics of basal cell carcinoma peritumoral stroma varies among basal cell carcinoma subtypes.
Lesack K; Naugler C
BMC Dermatol; 2012 Mar; 12():1. PubMed ID: 22405101
[TBL] [Abstract][Full Text] [Related]
20. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
